 |
OPCW |
Technical Secretariat |
| International
Cooperation and Assistance Division |
| S/339/2003 |
| 25
February 2003 |
| ENGLISH
only |
|
|
|
|
INVITATION TO
NOMINATE CANDIDATES TO A COURSE ON
THE MEDICAL ASPECTS
OF DEFENCE AGAINST CHEMICAL WEAPONS
TEHRAN, THE ISLAMIC
REPUBLIC OF IRAN
26 – 30 MAY 2003
1. On
behalf of the Government of the Islamic Republic of Iran and the Organisation
for the Prohibition of Chemical Weapons (OPCW),
the Director-General wishes to invite Member States to nominate candidates
to the fifth annual course on the medical aspects of defence against chemical
weapons (CWs), to be held from 26 to 30 May 2003, in Tehran, the Islamic Republic
of Iran.
2. The
course has been designed primarily for medical doctors, although candidates
from the paramedical professions will also be considered. The course will
be particularly valuable to medical professionals who are new to the field
of chemical defence, and who do not have an extensive background in the medical
aspects of defence against CWs. It will provide them with a unique opportunity
to gain insights from Iranian physicians who have treated victims of chemical
weapons in field situations.
3. The
purpose of the course is to assist Member States in the implementation of
programmes related to protection against CWs, in accordance with the second
part of paragraph 5 of Article X of the Chemical Weapons Convention, and
to improve their ability to make full use of the medical assistance that
may be provided in accordance with paragraphs 8 to 11 of Article X. Details
on what the course will cover appear in Annex 1 to this invitation.
4. Participants
will be provided with an overview of the nature of CWs and their effects,
and an update on international efforts to eliminate CWs. The course will
also enable medical personnel to gain an understanding of the problems they
might encounter if they participate in national or international responses
to incidents involving CWs, and also of the assistance and further training
that are available through the OPCW. In addition, it will provide an ideal
foundation to those who wish to attend specialised training courses offered
by other Member States in the future. It will combine theoretical lectures
with case studies involving patients who are undergoing treatment for the
chronic effects of exposure to CWs.
5. The
course will be held at the Centre for Treatment of Chemical Weapons Victims
in Tehran, the Islamic Republic of Iran.
6. All
activities during the course will be conducted in English. No interpretation
facilities of any kind will be provided. Nominated candidates are therefore
expected to have a good command of the English language, both oral and written.
7. Background
materials on the subjects the course will cover will be made available in
advance to the successful candidates, to allow them to prepare for the course.
Upon request, this material may be sent to the relevant permanent representations
to the OPCW in The Hague and Brussels, to be forwarded to participants.
8. The
OPCW expects to be able to cover the costs of travel, accommodation, and
meals for a limited number of participants nominated by Member States. When
proposing candidates for the course, Member States should specify whether
sponsorship is a condition of their participation.
9. Member
States are invited to submit the names of candidates for the course to the
Technical Secretariat no later than 31 March 2003. Nominations received
after that date will not normally be considered. All nominations, together
with a completed copy of the form that is included as Annex 2 to this invitation,
should be addressed to the Director, International Cooperation and Assistance
Division, OPCW, Johan de Wittlaan 32, NL-2517 JR The Hague, the Netherlands.
Applications may also be submitted by fax to +31 (0)70 416 3209, or by e-mail
to EmergAssistBr@opcw.org.
10. Additional
information on the course may be obtained from the International Cooperation
and Assistance Division, which can be contacted as specified in the previous
paragraph.
Annexes:
Annex 1: Subjects to Be Covered during the Course on the
Medical Aspects of Defence against Chemical Weapons
Annex 2: Questionnaire to be Completed by Candidates for
the Course on the Medical Aspects of Defence against Chemical Weapons
Annex 1
SUBJECTS TO BE
COVERED DURING THE COURSE ON THE
MEDICAL ASPECTS
OF DEFENCE AGAINST CHEMICAL WEAPONS
TEHRAN, THE ISLAMIC
REPUBLIC OF IRAN, 26 – 30 MAY 2003
1. GENERAL
INTRODUCTION
1.1 Overview
of the nature of chemical weapons and their effects
1.2 Introduction
to protection against CWs, including detection, personal and collective
protection, and contamination control
1.3 Using
chemical-defence equipment: performance reduction and ergonomic problems
2. THE
MEDICAL ASPECTS OF EXPOSURE TO CHEMICAL AGENTS
2.1 Nerve
agents (pathology, signs and symptoms, diagnosis and treatment)
2.2 Blister
agents (pathology, signs and symptoms, diagnosis and treatment)
2.3 Other
agents
3. THE
IRANIAN EXPERIENCE OF CHEMICAL WEAPONS
3.1 Review
of the experiences of, and the lessons learned by, Iranian physicians when
confronted
with mass CW casualties during
the 1980s
3.2 Organisation
of the medical response to a CW attack in the field
3.3 Organisation
and treatment of the chronic effects of CW poisoning, with an overview
of the work of the Iranian Veterans’ Foundation
3.4 Chronic
effects of exposure to mustard:
ˇ respiratory
effects
ˇ dermatological
effects
ˇ ophthalmological
effects
ˇ case
studies: guided clinical-training sessions, and interviews with and examinations
of patients exhibiting the chronic effects of exposure to mustard gas
4. INTERNATIONAL
EFFORTS AGAINST CHEMICAL WEAPONS
4.1 Update
on the implementation of the CWC, and the role of medical personnel in
chemical
defence and disarmament
4.2 Medical
aspects of investigations of alleged use of CWs
4.3 International
assistance for Member States of the OPCW
Annex 2
QUESTIONNAIRE
TO BE COMPLETED BY CANDIDATES FOR THE
COURSE ON ASPECTS
OF THE MEDICAL DEFENCE AGAINST CHEMICAL WEAPONS, TEHRAN, THE ISLAMIC REPUBLIC
OF IRAN, 26 – 30 MAY 2003
Please submit the
completed form no later than 31 March 2003 to:
The Director, International
Cooperation and Assistance Division, OPCW, Johan de Wittlaan 32,
2517
JR The Hague, the Netherlands
Fax: +31-(0)70-4163209;
e-mail: EmergAssistBr@opcw.org
Family name: ___________________________ First name(s):
_____________________________
Date of birth: ___________________________ Nationality:
______________________________
Gender:
______________________________ E-mail:
__________________________________
Tel.
No: ______________________________ Fax
No:__________________________________
Present
Address: ______________________________________________________________
__________________________________________________________
Professional qualifications
| University or
Institute Name, Place, and Country |
Attendance
Dates |
Degree or Diploma
Obtained |
Main Area of
Study |
| From |
To |
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Experience and career summary:
Please provide a short overview of your professional career,
covering in particular any areas that you believe would be of special interest
to the review panel:
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Have you had any previous training in the medical defence
against CWs?
Yes No If
so, please provide details:
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Have you had any actual experience examining or treating
patients who have been exposed to CWs?
Yes No If
so, please provide details:
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
What is your current or expected future involvement in the
medical defence against CWs?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
- - - o - - -